Works by Wigger-Alberti, W.


Results: 27
    1
    2
    3
    4
    5

    A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis.

    Published in:
    Clinical & Experimental Dermatology, 2021, v. 46, n. 1, p. 122, doi. 10.1111/ced.14412
    By:
    • Berstein, G.;
    • Zhang, Y.;
    • Berger, Z.;
    • Kieras, E.;
    • Li, G.;
    • Samuel, A.;
    • Yeoh, T.;
    • Dowty, H.;
    • Beaumont, K.;
    • Wigger‐Alberti, W.;
    • Mackensen, Y.;
    • Kroencke, U.;
    • Hamscho, R.;
    • Garcet, S.;
    • Krueger, J. G.;
    • Banfield, C.;
    • Oemar, B.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Oral rush desensitization to milk.

    Published in:
    Allergy, 1999, v. 54, n. 8, p. 0, doi. 10.1034/j.1398-9995.1999.00228.x
    By:
    • Bauer, A;
    • Ekanayake Mudiyanselage, S;
    • Wigger-alberti, W;
    • Elsner, P
    Publication type:
    Article
    26
    27